Nanobiotix S.A. (NANO.PA)
| Previous Close | 6.21 |
| Open | 6.24 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 6.16 - 6.50 |
| 52 Week Range | 4.23 - 10.40 |
| Volume | |
| Avg. Volume | 43,715 |
| Market Cap | 300.098M |
| Beta (5Y Monthly) | 1.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
11 Best Nanotechnology Stocks To Invest In
In this piece, we will take a look at the 11 best nanotechnology stocks to invest in. If you want to skip our introduction to the nanotechnology sector and how it covers a variety of applications ranging from healthcare to consumer technology, then you can skip ahead to read 5 Best Nanotechnology Stocks To Invest […]
- GuruFocus.com
Baillie Gifford Bolsters Stake in Nanobiotix SA
Baillie Gifford (Trades, Portfolio), the renowned investment management firm, has recently increased its investment in Nanobiotix SA, a company at the forefront of nanotechnology in cancer treatment. This transaction was executed at a trade price of $5.81 per share, reflecting a 48.18% change in the firm's holdings and a 6.21% ownership in Nanobiotix SA. Despite the significant addition, the trade had a negligible impact on Baillie Gifford (Trades, Portfolio)'s portfolio, with the position accounting for just 0.02% of its total investments.
